GA
TGTX icon

Guerra Advisors’s TG Therapeutics TGTX Stock Holding History

Guerra Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$181 Buy
+5
New +$165 ﹤0.01% 863

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guerra Advisors's TGTX Position: Q3 2025 in Review

Guerra Advisors opened a new position in TG Therapeutics (TGTX) in Q3 2025: 5 shares worth $181. The stake represents ﹤0.01% of the portfolio and ranks #863 among its holdings.

354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

  • Guerra Advisors held 5 shares of TG Therapeutics worth $181 as of Q3 2025.
  • TG Therapeutics was a new Guerra Advisors position in Q3 2025.
  • TG Therapeutics made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #863 holding.
  • 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.